Boston City Hosp / FGH-1 — Boston, Massachusetts

Boston City Hosp / FGH-1 is a clinical research site located in Boston, Massachusetts, United States 02118.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Boston City Hosp / FGH-1 has participated in 4 clinical trials.

Therapeutic areas: HIV Infections.

Sponsors: Pharmacia and Upjohn, Glaxo Wellcome.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Boston City Hosp / FGH-1?

Boston City Hosp / FGH-1 has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Boston City Hosp / FGH-1 conducted?

Boston City Hosp / FGH-1 has 4 clinical trials on record. Their work covers HIV Infections.

Is Boston City Hosp / FGH-1 accredited by Crixeo Health?

Boston City Hosp / FGH-1 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Boston City Hosp / FGH-1?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.